Thus, in most malignant cells as in early developing colorectal cancer (84), nonsmall cell lung cancer (308), leukemia (326), and pancreatic cancer UCP2 levels are elevated (108, 251). This evidence concerns the gene UCP2 and pancreatic neoplasm.